Poland· PL-100235556
Melodyn
A buprenorphine product containing buprenorphinum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Buprenorphine is registered in 13 of 19 countries.
Countries holding a registration under ATC N02AE01 (buprenorphine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Buprenorphine · ATC N02AE01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of buprenorphine costs, country by country.
Normalised to the WHO defined daily dose (1.2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Buprenorphine · price per daily dose (1.2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.77
The record
At a glance
URPL (Poland)- Active substance
- Buprenorphinum
- Manufacturer
- G.L. Pharma GmbH
- Country
- Poland (PL)
- ATC code
- N02AE01
- ATC class
- Buprenorphine
- Defined daily dose
- 1.2 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 7
1 priced- gtin059099909380875 szt.PLN 81.19
- gtin05909990809981
- gtin05909990809998
- gtin05909990810000
- gtin05909990938094
- gtin05909990938100
- gtin05909991058555
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
378 interactions on record for buprenorphine.
Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Buprenorphine · interactions on record
378 records
- 59 severe
- 253 moderate
- 2 minor
- 52 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- DronabinolA04AD10severe
12 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Buprenorphine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBUPRENORFIN MYLANMylan Ireland Limited, Dublin
- BelgiumBuprenorfine Sandoz 52.5 µg/hSandoz
- SpainTRANSTEC 52,5 microgramos/H PARCHE TRANSDERMICOGrünenthal Pharma S.A.
- IrelandTranstec 52.5 micrograms/h Transdermal PatchGrünenthal GmbH
- ItalyTRANSTECGRUNENTHAL ITALIA S.R.L.
- United KingdomBunov 10micrograms/hour transdermal patchesGlenmark Pharmaceuticals Europe Ltd
- United StatesBELBUCABioDelivery Sciences International Inc
- SwedenBuprefarm 10 mikrogram/timme DepotplåsterOrifarm Generics A/S
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Astec, Bupensan
- Belgium · Temgesic, Transtec
- Bulgaria · Бупренорфин G.L., Бупренорфин Актавис
- Cyprus · Buvera
- Czechia · Addnok, Buprenorfin Stada
- Germany · Acimaphin, Acinorphin
- Denmark · Buprefarm, Bupremyl
- Estonia · Buprenorphine G.L. Pharma
- Spain · Buprenorfina Andrómaco, Buprenorfina Sandoz
- Finland · Buprefarm, Bupremyl
- France · Bupensan, Buprenorphine Arrow
- United Kingdom (Northern Ireland) · Addnok, Bunov
- Greece · Buprenal, Buvera
- Croatia · Buprenorfin Alkaloid, Buprenorfin Sandoz
- Ireland · Buprenorphine Activase Pharmaceuticals, Buprenorphine Morningside Healthcare
- Iceland · Buprenorphine Alvogen, Buprenorphine Neuraxpharm
- Italy · Buprenorfina Molteni, Buprenorfina Sandoz
- Liechtenstein · Buprenorphine Neuraxpharm, Buvidal
- Luxembourg · Temgesic, Temgesic Sublingualis
- Latvia · Buprenorphine G.L. Pharma
- Malta · Buprenorphine Aspire Pharma (Malta), Natzon
- Netherlands · Buprenorfine, Buprenorfine 1a Pharma
- Norway · Bugnanto, Buprefarm
- Portugal · Buprenorfina, Buprenorfina Aurovitas
- Sweden · Buprefarm, Buprenorfin Actavis
- Slovenia · Addnok, Buprenorfin Alkaloid-Int
- Slovakia · Bupretec, Noprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/62f9c7c7-df25-4b8d-bdf0-3e6afdd1d11a GET /v1/drugs/62f9c7c7-df25-4b8d-bdf0-3e6afdd1d11a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "System transdermalny",
"source": "urpl",
"strength": "52,5 mcg/h",
"packaging": "05909990809981 ¦ Rp ¦ 43529\n4 plastry\n05909990809998 ¦ Rp ¦ 43530\n8 plastrów\n05909990810000 ¦ Rp ¦ 44464\n16 plastrów\n05909990938087 ¦ Rp ¦ 53020\n5 plastrów\n05909990938094 ¦ Rpw ¦ Skasowane ¦ 54820\n10 sasz. \n05909990938100 ¦ Rpw ¦ Skasowane ¦ 55449\n20 sasz. \n05909991058555 ¦ Rp ¦ 83902\n10 plastrów",
"substance": "Buprenorphinum 30 mg",
"common_name": "Buprenorphinum",
"pl_product_id": "100235556",
"pozwolenie_nr": "17384",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about buprenorphine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.